Skip to main content

and
  1. No Access

    Article

    Die operative Therapie des Vulvakarzinoms

    Die Prognose des Vulvakarzinoms wird wesentlich durch die operative Therapie bestimmt. Neben der onkologischen Sicherheit müssen rekonstruktive Maßnahmen Berücksichtigung finden. Die Erkrankung tritt immer häu...

    PD Dr. med. J. Gallwas, C. Dannecker, T. Eggersmann, J. Jückstock in Der Gynäkologe (2017)

  2. No Access

    Article

    Entzündliche Erkrankungen des Uterus und der Adnexe

    Entzündliche Erkrankungen von Uterus und Adnexen entstehen meist durch vaginale Keimaszension, seltener durch intraabdominale Prozesse, und werden als „pelvic inflammatory disease“ (PID) bezeichnet. Die Klinik...

    Dr. J. Jückstock, T. Blankenstein, S. Mahner, I. Mylonas in Der Gynäkologe (2016)

  3. No Access

    Article

    Multiresistente Keime

    Die Zunahme von durch multiresistente Erreger (MRE) verursachten Infektionen stellt ein mittlerweile weltweites Problem dar. Dabei ist die Entwicklung von Antibiotikaresistenzen v. a. auf übermäßigen Antibioti...

    Dr. Julia Jückstock, T. Blankenstein, K. Friese in Der Gynäkologe (2015)

  4. No Access

    Article

    Point-of-care (POC) diagnosis of bacterial vaginosis (BV) using VGTest™ ion mobility spectrometry (IMS) in a routine ambulatory care gynecology clinic

    A new CE-marked portable desktop ion mobility spectrometer (VGTest) was used for detection of malodorous biogenic amines indicative of bacterial vaginosis (BV). This study aimed to assess the performance of th...

    T. Blankenstein, S. D. Lytton, B. Leidl, E. Atweh in Archives of Gynecology and Obstetrics (2015)

  5. No Access

    Article

    Allogeneic gene-modified tumor cells (RCC-26/IL-7/CD80) as a vaccine in patients with metastatic renal cell cancer: a clinical phase-I study

    Despite novel targeted agents, prognosis of metastatic renal cell cancer (RCC) remains poor, and experimental therapeutic strategies are warranted. Transfection of tumor cells with co-stimulatory molecules and...

    J Westermann, A Flörcken, G Willimsky, A van Lessen, J Kopp, A Takvorian in Gene Therapy (2011)

  6. No Access

    Article

    The immune response to sporadic colorectal cancer in a novel mouse model

    Current mouse models do not reflect the sporadic nature of colon cancer and do not allow the analysis of antitumor immune response because of the lack of known tumor-specific antigens. Two transgenic mouse mod...

    M Czéh, C Loddenkemper, S Shalapour, C Schön, S Robine, E Goldscheid, H Stein in Oncogene (2010)

  7. No Access

    Article

    In vivo splenic CD11c cells downregulate CD4 T-cell response thereby decreasing systemic immunity to gene-modified tumour cell vaccine

    One of the factors influencing the efficacy of tumour cell vaccines is the site of immunization. We have shown previously that gene-modified vaccines delivered directly inside the spleen induced antigen cross-...

    S Cayeux, B Bukarica, C Buschow, J Charo, M Bunse, B Dörken, T Blankenstein in Gene Therapy (2007)

  8. No Access

    Article

    Adenoviral transduction of tumor cells induces apoptosis in co-cultured T lymphocytes

    Adenoviral gene transfer of immunmodulatory molecules has been employed successfully in tumor vaccination studies to induce rejection of transplanted syngeneic tumors. In contrast, the response observed when t...

    C Scholz, L Stärck, G Willimsky, T Blankenstein, B Dörken, P T Daniel in Gene Therapy (2002)

  9. No Access

    Article

    Expression of B7.1 (CD80) in a renal cell carcinoma line allows expansion of tumor-associated cytotoxic T lymphocytes in the presence of an alloresponse

    We have selected a well-characterized human renal cell carcinoma (RCC) line as the basis for development of a genetically engineered tumor cell vaccine to be applied in an allogeneic setting. This cell line wa...

    DJ Schendel, B Frankenberger, P Jantzer, S Cayeux, E Nöβner, G Willimsky in Gene Therapy (2000)

  10. No Access

    Article

    Bcr/abl+ autologous dendritic cells for vaccination in chronic myeloid leukemia

    In chronic myeloid leukemia (CML) ex vivo generated DC are characterized by constitutive expression of bcr/abl and possibly other yet undefined leukemia-associated antigens, since these DC share a common progeny ...

    J Westermann, J Kopp, I Körner, G Richter, Z Qin in Bone Marrow Transplantation (2000)

  11. No Access

    Article

    Allogeneic vaccination for renal cell carcinoma: development and monitoring

    An allogeneic tumor cell vaccine should display a natural immunogenicity that allows the stimulation of tumor-reactive effector cells in patients. Furthermore, the vaccine should express antigens that are shar...

    H Pohla, B Frankenberger, B Stadlbauer, R Oberneder in Bone Marrow Transplantation (2000)

  12. No Access

    Chapter and Conference Paper

    Schnelle Etablierung humaner Mammakarzinomzellinien durch SV40 large T Antigen-Immortalisierung: Ein neuer Ansatz für gentherapeutische Strategien?

    Hintergrund und Fragestellung: Die Etablierung von humanen Zellinien wurde bisher häufig limitiert durch die in der Regel nach einigen Passagen auftretende Krise der Zellen in Kultur. Zur Charakt...

    Dr. Karin Schumacher, L.-P. Li in Chirurgisches Forum 2000 für experimentell… (2000)

  13. No Access

    Chapter

    Vaccines using Gene-Modified Tumor Cells

    To date, many cytokines and costimulatory molecules have been transfected in a number of different rodent tumors and in several cases, these gene modified tumor cells, when used as vaccines, induced tumor immu...

    S. Cayeux, Z. Qin, B. Dörken, T. Blankenstein in Gene Therapy (1999)

  14. No Access

    Article

    Loss of retroviral gene expression in bone marrow reconstituted mice correlates with down-regulation of gene expression in long-term culture initiating cells

    The question of whether a retroviral vector is expressed in vivo after infection of hematopoietic stem cells remains unpredictable. In this study, we show that a switch off of retroviral sequences can be teste...

    C Lange, T Blankenstein in Gene Therapy (1997)

  15. No Access

    Chapter

    Influence of Local Cytokines on Tumor Metastasis: Using Cytokine Gene-Transfected Tumor Cells As Experimental Models

    The molecular mechanisms and, in particular, the role of cytokines involved in the process of metastasis, though one of the most important aspects of cancer research, are largely unknown. In order to metastasi...

    Z. Qin, T. Blankenstein in Attempts to Understand Metastasis Formation III (1996)

  16. No Access

    Article

    Expression of interleukin 10 in human melanoma

    The expression of interleukin 10 (IL-10) mRNA in human malignant melanoma was investigated by reverse transcriptase polymerase chain reaction analysis. Selective expression of IL-10 mRNA in tissues of primary ...

    S Krüger-Krasagakes, K Krasagakis, C Garbe, E Schmitt, C Hüls in British Journal of Cancer (1994)

  17. No Access

    Chapter and Conference Paper

    Risiko der Rektumchirurgie im hohen Alter

    Colorectal cancer is the second frequent cancer as well in man as in woman. Expecting a steep increase of old persons in the following years the risk of colorectal cancer surgery with priority of rectal cancer...

    K. Wellmann, T. Blankenstein, B. Ulrich in Wandel der Chirurgie in unserer Zeit (1993)

  18. No Access

    Chapter and Conference Paper

    Cytokine Involvement in Tumor Development and Tumor Suppression

    Cytokines constitute a class of soluble small proteins which previously have been designated monokines, lymphokines, or interleukins. They represent the intercellular signaling system for hematopoiesis and imm...

    M. Dorsch, T. Diamantstein, T. Blankenstein in Cytokines in Hemopoiesis, Oncology, and AI… (1992)